Target intelligence / Profile preview

Gastric acid and pepsin

Molecular classification
Enzyme, Inorganic ion
01

Overview

Gastric luminal protons (hydrochloric acid) and pepsin activity represent the primary aggressive factors in the stomach's digestive environment (StatPearls, NBK535425). Hydrochloric acid is secreted by parietal cells via the H+/K+ ATPase pump, creating a highly acidic environment (pH 1-3) necessary for the activation of the zymogen pepsinogen into the active protease pepsin (PubChem, CID 16218657). Pepsin is a major aspartic protease responsible for the initial digestion of dietary proteins by cleaving peptide bonds (PubMed, 17478444). While essential for nutrient breakdown and defense against ingested pathogens, an imbalance between these aggressive factors and mucosal defensive mechanisms (such as mucus and bicarbonate) leads to acid-peptic diseases. These conditions include peptic ulcer disease, gastroesophageal reflux disease (GERD), and laryngopharyngeal reflux (LPR), where pepsin can cause extra-gastric tissue damage even at non-acidic pH levels (StatPearls, NBK534792). Therapeutic strategies targeting these luminal factors include direct neutralization of protons using antacids and the use of cytoprotective agents like sucralfate or alginates that sequester pepsin and provide a physical barrier against acid-induced injury (StatPearls, NBK551527).

Other names
Gastric luminal protonsPepsin activityAcid-pepsin complexGastric juice acidityGastric luminal environment
02

Mechanism of action

Direct chemical neutralization of luminal protons and sequestration or inhibition of pepsin proteolytic activity.

03

Biological functions

DigestionProteolysisAntimicrobial defenseProtein denaturation
04

Disease associations

Gastroesophageal reflux disease (GERD)Peptic ulcer disease (PUD)GastritisLaryngopharyngeal reflux (LPR)Zollinger-Ellison syndrome
05

Safety considerations

Electrolyte imbalance (e.g., hypermagnesemia, hypercalcemia)Acid rebound effectAltered drug absorption due to pH changesAluminum toxicity in renal impairmentMilk-alkali syndrome
06

Interacting drugs

Aluminum hydroxide

6 more in the full profile.

07

Biomarkers

Gastric pHSalivary pepsin levelsBasal acid output (BAO)Maximal acid output (MAO)

Beyond the preview

Go deeper on Gastric acid and pepsin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gastric acid and pepsin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call